Concurrent chemotherapy and hypofractionated twice-daily radiotherapy in cervical cancer patients with stage IIIB disease and bilateral parametrial involvement: A phase I-II study

International Journal of Radiation Oncology Biology Physics

Volumn 60, Issue 4, 2004, Pages 1154-1159

  Viegas, Celia M ^a   Araujo, Carlos M M ^a   Dantas, Mario A ^a   Froimtchuk, Miguel ^a   Oliveira, Jose A F ^a   Marchiori, Edson ^b   Souhami, Luis ^c,d  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c MCGILL UNIVERSITY   (Canada)

^d MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Bilateral parametrial involvement; Cervical cancer; Combined radiotherapy and chemotherapy; Hypofractionation; Stage IIIB disease

Indexed keywords

CELLS; CHEMOTHERAPY; PARAMETER ESTIMATION; PATIENT MONITORING; TOXICITY; TUMORS;

ACUTE TOXICITY; BRACHYTHERAPY; CERVICAL CANCER; SURVIVAL RATES;

RADIOTHERAPY;

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD TOXICITY; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG TOLERABILITY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; NAUSEA; NEPHROTOXICITY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TOXICITY; UTERINE CERVIX CANCER; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; UTERINE CERVICAL NEOPLASMS;

EID: 7444228642     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.04.053     Document Type: Article

References (19)

1. Parkin D.M. Global cancer statistics in the year 2000. Lancet Oncol. 2:2001;533-543
2. Ferrigno R., Faria S.L.C.O., Weltman E., et al. Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low-dose-rate brachytherapy Retrospective analysis of results and variables. Int J Radiat Oncol Biol Phys. 55:2003;695-706
3. Manji M.F., Pradhan D., El-Senoussi M., et al. Carcinoma of cervix, the King Faisal Specialist Hospital & Research Center Experience - The need for screening for cervical cancer in developing countries. Eur J Gynaecol Oncol. 20:1999;412-415
4. Stehman F.B., Perez C.A., Kurman R.J., et al. Uterine cervix. Hoskins W.J., Perez C.A., Young R.C. Principles and practice of gynecology oncology. 2000;841-918 Lippincott Williams & Wilkins, Philadelphia
5. Souhami L., Melo J.A., Pareja G. The treatment of stage III carcinoma of the uterine cervix with telecobalt irradiation. Gynecol Oncol. 28:1987;262-267
6. Lanciano R.M., Won M., Coia L.R., et al. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix A final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys. 204:1991;667-676
7. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 340:1999;1137-1143
8. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 340:1999;1144-1153
9. Whitney C.W., Sause W., Bundy B.N., et al. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. A Gynecology Oncology Group and Southwest Oncology Group Study. J Clin Oncol. 17:1999;1339-1348
10. Eifel P.J., Winter K., Morris M., et al. Pelvic radiation with concurrent chemotherapy versus pelvic and para-aortic radiation for high-risk cervical cancer An update of RTOG 90-01 [Abstract]. Int J Radiat Oncol Biol Phys. 54:(Suppl. 2):2002;1
11. Housset M., Maulard C., Chretien Y., et al. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder A prospective study. J Clin Oncol. 11:1993;2150-2157
12. Kaufman D.S., Winter K.A., Shipley W.U., et al. The initial results in muscle-invading bladder cancer of RTOG 95-06 Phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response. Oncologist. 56:2000;471-476
13. International Commission of Radiation Units and Measurements. Dose and volume specifications for reporting intracavitary therapy in gynecology: ICRU report 38. 1985;International Commission of Radiation Units and Measurements, Bethesda
14. Kaplan E.L., Meier R. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481
15. Kirwan J.M., Symonds P., Green J.A., et al. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol. 68:2003;217-226
16. Housset M., Dufour B., Maulard-Durdux C., et al. Concomitant fluorouracil (5-FU)-cisplatin (CDDP) and bifractionated split course radiation therapy (BSCRT) for invasive bladder cancer [Abstract]. Proc ASCO. 16:1997;319a
17. Petereit D.G., Sarkaria J.N., Hartmann T.J., et al. Adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys. 32:1995;1301-1307
18. Schwachöfer J.H.M., Crooijmans R.P.M.A., Hoogenhout J., et al. Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin Influence of treatment sequence. Int J Radiat Oncol Biol Phys. 20:1991;1235-1241
19. Hopkins H.A., Looney W.B. Solid tumor models for the assessment of different treatment modalities XXVI. Estimates of cell survival from tumor growth delay after alternating radiotherapy and chemotherapy. Int J Radiat Oncol Biol Phys. 13:1987;217-224